Patient‐reported outcomes in multiple sclerosis: a systematic comparison of available measures

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Neurology

• Publication date

  2017-07-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ene.13339PMID 28695634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis

  2014cited by this paper
• Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments

  2014cited by this paper
• Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening

  2014cited by this paper
• Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures

  2014cited by this paper
• Evaluation of shoulder-specific patient-reported outcome measures: a systematic and standardized comparison of available evidence.

  2014cited by this paper
• Patient reported outcome measures could help transform healthcare

  2013cited by this paper
• Further validation of multiple sclerosis walking scale-12 scores based on spatiotemporal gait parameters.

  2013cited by this paper
• Quality of Life Outcomes in Multiple Sclerosis: A Review of the Literature

  2013cited by this paper
• Validation of the Multiple Sclerosis International Quality of Life Questionnaire in Electronic Form Using Item Response Theory

  2013cited by this paper
• Burden of a Multiple Sclerosis Relapse

  2012influential reference
• Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis

  2011cited by this paper
• The differential mediating effects of pain and depression on the physical and mental dimension of quality of life in Hong Kong Chinese adults

  2010cited by this paper
• The routine use of patient reported outcome measures in healthcare settings

  2010cited by this paper
• Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS)

  2010cited by this paper
• The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study

  2010cited by this paper
• International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS).

  2010cited by this paper
• Responsiveness of patient-based and external rating scales in multiple sclerosis: head-to-head comparison in three clinical settings.

  2010cited by this paper
• Multiple Sclerosis Walking Scale-12 and oxygen cost of walking.

  2010cited by this paper
• The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)

  2009cited by this paper
• Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study

  2009cited by this paper
• Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study

  2009cited by this paper
• Development of EMPRO: a tool for the standardized assessment of patient-reported outcome measures.

  2008influential reference
• Validation of the Multiple Sclerosis International Quality of Life questionnaire

  2008cited by this paper
• The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite

  2008cited by this paper
• Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).

  2008cited by this paper
• Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.

  2007cited by this paper
• Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study.

  2007cited by this paper
• The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)

  2007cited by this paper
• Self-perceived limitations of gait in persons with multiple sclerosis

  2007cited by this paper
• Patient-reported Outcome Measures in Multiple Sclerosis.

  2006cited by this paper
• Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment

  2006cited by this paper
• Health and Quality of Life Outcomes

  2006cited by this paper
• How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales

  2005cited by this paper
• Health-related quality of life in multiple sclerosis: psychometric analysis of inventories

  2005cited by this paper
• Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12)

  2004cited by this paper
• The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure

  2004cited by this paper
• Measuring the impact of MS on walking ability

  2003cited by this paper
• Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures

  2003cited by this paper
• Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales

  2003cited by this paper
• Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

  2002cited by this paper
• Disease specific quality of life instruments in multiple sclerosis: Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS)

  2001cited by this paper
• Developing a disease-specific quality of life measure for people with multiple sclerosis

  2001cited by this paper
• The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.

  2001cited by this paper
• Validation of Italian multiple sclerosis quality of life 54 questionnaire

  1999cited by this paper
• Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument

  1996cited by this paper
• A health-related quality of life measure for multiple sclerosis

  1995cited by this paper

• From checkboxes to emojis: a novel approach to patient-reported outcomes in multiple sclerosis

  2025cites this paper
• Which type of PROMs to use in MS routine clinical care: The validity of PROMIS CAT questionnaires.

  2025cites this paper
• Barriers to care for people with unclear visual loss—Data from a tertiary-level-of-care neuroinflammation center

  2025cites this paper
• Placebo Responses in Trials for Multiple Sclerosis.

  2025cites this paper
• The importance of patient-reported outcomes: A call for their integration in the routine care of patients with multiple sclerosis

  2025cites this paper
• Effects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the “power training in older multiple sclerosis patients (PoTOMS) randomized control trial

  2024cites this paper
• Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges.

  2024cites this paper
• Clinical outcome assessment in patients with epilepsy: The value of health-related quality of life measurements.

  2024cites this paper
• A systematic literature review of the measurement of patient-reported fatigue in studies of disease modifying therapies for multiple sclerosis.

  2024cites this paper
• Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis

  2024cites this paper
• Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy

  2024cites this paper
• How to measure the treatment response in progressive multiple sclerosis: Current perspectives and limitations in clinical settings'.

  2023cites this paper
• Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes.

  2023cites this paper
• Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

  2023cites this paper
• Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies

  2023cites this paper
• Patient-reported outcomes and pharmacist actions in patients with multiple sclerosis managed by health-system specialty pharmacies.

  2023cites this paper
• Applying multidimensional computerized adaptive testing to the MSQOL-54: a simulation study

  2023cites this paper
• Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?

  2022cites this paper
• The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosis.

  2022cites this paper
• Literatur

  2022cites this paper
• Incomplete reporting of patient-reported outcomes in multiple sclerosis: A meta-epidemiological study of randomized controlled trials.

  2022cites this paper
• Neurologists’ views on patient reported outcomes in multiple sclerosis care

  2022cites this paper
• Patient involvement in the development of PROMs within the MS Field: A systematic review

  2022cites this paper
• Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

  2022cites this paper
• Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study

  2022cites this paper
• Relevance and Impact of Social Support on Quality of Life for Persons With Multiple Sclerosis.

  2022cites this paper
• Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial

  2022cites this paper
• Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis

  2022cites this paper
• Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol

  2022cites this paper
• Prediction in treatment outcomes in multiple sclerosis: challenges and recent advances

  2021cites this paper
• Coping strategies: Seeking personalized care in relapsing-remitting multiple sclerosis. A patient reported measure–coping responses inventory

  2021cites this paper
• Translation, cross‐cultural adaptation, and reliability and validity of the Turkish version of the SF‐Qualiveen in people with multiple sclerosis

  2021cites this paper
• Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis.

  2021cites this paper
• Deciphering Multiple Sclerosis Progression

  2021cites this paper
• Focus group on the experience of patients and family members in the multiple sclerosis unit of a tertiary hospital

  2021cites this paper
• The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study

  2021cites this paper
• Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review

  2021cites this paper
• A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease

  2021cites this paper
• Measuring Treatment Response in Progressive Multiple Sclerosis—Considerations for Adapting to an Era of Multiple Treatment Options

  2021cites this paper
• The 27-Item Multiple Sclerosis Quality of Life Questionnaire: A New Brief Measure Including Treatment Burden and Work Life.

  2021cites this paper
• NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights.

  2021cites this paper
• Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective

  2020cites this paper
• Factors associated with early postoperative survey completion in orthopaedic surgery patients.

  2020cites this paper
• Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND

  2020cites this paper
• Patient‐ versus physician‐reported relapses in multiple sclerosis: insights from a large observational study

  2020cites this paper
• PPA_A_248272 869..880

  2020cites this paper
• Grupo focal sobre la experiencia de pacientes y familiares en la unidad de esclerosis múltiple de un hospital terciario

  2020cites this paper
• A longitudinal study of symptom botheration in Multiple Sclerosis.

  2020cites this paper
• Der Patient als Experte

  2020influential citation
• Relapses in multiple sclerosis reported by patients versus physicians - Insights from a large observational study.

  2020cites this paper
• Therapeutic status quo in patients with relapsing-remitting multiple sclerosis: A sign of poor self-perception of their clinical status?

  2020cites this paper
• Smartphone- and Smartwatch-Based Remote Characterisation of Ambulation in Multiple Sclerosis During the Two-Minute Walk Test

  2020cites this paper
• Identifying Progression In Multiple Sclerosis: New Perspectives.

  2020cites this paper
• Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study

  2020cites this paper
• Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis

  2020cites this paper
• Clinical outcome measures in multiple sclerosis: A review.

  2020cites this paper
• The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study (Preprint)

  2020cites this paper
• Individualized behaviour change strategies for physical activity in multiple sclerosis (IPAC-MS): protocol for a randomized controlled trial

  2019cites this paper
• Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives

  2019cites this paper
• Individualised behaviour change strategies for physical activity in multiple sclerosis (IPAC-MS): protocol for a randomised controlled trial

  2019cites this paper
• Does Resetting the Immune System Fix Multiple Sclerosis?

  2019cites this paper
• Life domains that are important to quality of life for people with multiple sclerosis: A population-based qualitative analysis

  2019cites this paper
• Activity limitations and participation restrictions in people with multiple sclerosis: a detailed 10-year perspective

  2019cites this paper
• Review: Patient-reported outcomes in multiple sclerosis care.

  2019cites this paper
• eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54

  2019cites this paper
• Progress in neurology 2017–2018

  2018cites this paper
• Health state utility values among children and adolescents with disabilities: protocol for a systematic review

  2018cites this paper
• Assessing oral health-related quality of life in children and adolescents: a systematic review and standardized comparison of available instruments

  2018cites this paper
• The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study.

  2017cites this paper
• Self-reported physical activity correlates in Swedish adults with multiple sclerosis: a cross-sectional study

  2017cites this paper